Aktuel forskning

Cells of the immune system, e.g., NK and T cells are capable of recognizing cancer cells. However, the infiltration of these cells to the tumor site may be too limited for clinical significance, or the killing capacity of T and NK cells is hampered in the tumor microenvironment by various mechanisms. We study how immune cells with capacity to kill cancer cells can reach the tumor site in higher numbers and with better functional capacity.

Our vision is to unravel mechanisms by which cancer cells avoid killing by cells of the immune system, and use that as a platform for development of novel cancer therapies. My group is international and we collaborate with scientists and clinicians in Denmark and abroad.

Undervisnings- og vejledningsområder

Responsible for the program “The Immune Defence and Cancer” (http://kurser.ku.dk/course/siik16003u/2017-2018), which is part of the master in Immunology and Inflammation (http://studies.ku.dk/masters/immunology-and-inflammation/). Beyond that regular teaching of undergraduate students at the Faculty of Health and Medical Sciences, University. Master and PhD students are supervised during the education in the lab.

Aktuel forskning

English presentation

CV

English CV